Cell Counting Market, By Product (Instruments and Consumables & Accessories), By End-user (Research & Academic Institutes, Hospitals & Diagnostic Labs, Biotechnology & Pharmaceutical Companies, and Others) – By Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) – Market Trends, Analysis, and Forecast Till 2029

Cell counting instruments are increasingly being adopted in various areas of research such as cancer biology, immunology, and neuroscience, which exhibits remunerative growth opportunities for the market.  Cell counting is a method used for the counting or for the quantification of cells in the life sciences, which includes medical diagnosis and treatment. Cell counting is an important division of cytometer, which have applications in research and clinical practices. For instance, for medicine and biological procedures require the cell counting which enables to known the volume, concentration for the medication. The growth of the cell counting market is driven due to the rising demand from biopharmaceutical companies and the research institutes, academic institutes for the increasing cytological studies. In addition, increasing expenditures by the government for research & developments are also leading to the growth of the cell counting market. The introduction of advanced equipment for cell counting in the developing regions such as Asia Pacific and Middle East & Africa can create opportunities for companies manufacturing cell counting instruments and reagents.

Impact of COVID-19 on Cell Counting

The COVID-19 pandemic has had a major impact on the way of life across the world. Every business has to fight the battle for both health and economic. According to situation, predictions gives intimation that recovery period might run well into early next year. Cell counting is being highly demanded during coronavirus pandemic, as cell counting helps to diagnose the cell count and function of T cells and cytokines concentrations in COVID-19 patients. The funding for cell-based research, rising incidence of chronic and infectious diseases, growing biotechnology and biopharmaceutical industries, development of enhanced solutions, growing use of high-throughput flow cytometry,  and automated hematology analyzers are the few factors responsible for growth of the market over the forecast period.

Global cell counting market primarily attributed to the major drivers in this market such as the increased need for non-invasive diagnosis, advancements in single cell sequencing technique and increase in adoption of personalized medicine. These individualized care regimes are improving quality of life of the patients and reducing economic, societal, and clinical burden, projecting a future of prosperity.

The applications of single cell multi-omics primarily include oncology, cell biology, neurology, stem cell, and immunology, among others. Aside from the discovery of effective biomarkers for the development of efficient targeted drug therapy, single cell approach also facilitates gene expression and protein expression analyses in an individual cell. Research and academic organizations, biotechnology and biopharmaceutical companies, and diagnostic centers, among others, are prominent end users of single cell multi-omics solutions.

The global cell counting is segmented based on the product, end user, and region.

Based on the product the global market is segmented into instruments and consumables & accessories. The instruments segment is further sub segmented as spectrometers, flow cytometers, hematology analyzers and cell counters. Similarly, the consumables & accessories is segmented as kits and reagents, accessories, and others. Spectrophotometers are predicted to hold the largest market share due to its capability to measure different intensities of light accuracy and its applications in bioprocessing, therapeutics, and research.

Based on the application, the market is bifurcated into research institutes, hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies, and others. Hospitals & diagnostic laboratories are anticipated to have the highest CAGR in the forecast period. The factors can be attributed to the rising pharmaceutical R&D expenditure and increasing regulatory approvals for cell culture-based vaccines.

Regional insights:

According to the region, market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to dominate the cell counting market followed by Europe in the global scenario leading to various technological developments in the healthcare industry and rising research activities in the cytology with more funds available by the government. Asia Pacific market is expected to witness significant growth rate during the forecast period owing to the opportunities in the emerging economies and increasing R&D expenditures for the healthcare sectors.

Detail Segmentation:

Segments covered in the report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029.  For the purpose of this study, has segmented the global cell counting market report based on product, end-user, and region.

Global Cell Counting Market, By Product:

• o Instruments

• o Spectrometers
• o Flow cytometers
• o Hematology analyzers
• o Cell counters.

• o Consumables & Accessories

• o Kits and reagents
• o Accessories
• o Other

Global Cell Counting Market, By End User:

• o Research & Academic Institutes
• o Hospitals & Diagnostic Labs
• o Biotechnology & Pharmaceutical Companies
• o  Others

Global Cell Counting Market, By Region:

• North America

• o U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The major companies in the cell counting market include Danaher Corporation, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Merck KGaA, and Bio-Rad Laboratories. Danaher is a global leader in the cell counting market. The company operates in more than 60 countries and has a broad product portfolio in instruments and consumables in the cell counting segment. The product portfolio includes mass spectroscopy, microplate readers, assay kits, flow cytometry, and reagents. Danaher has undertaken several acquisitions to continue developing cell counting products in this market. 

• Danaher Corporation
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
• Thermo Fisher Scientific Inc.
• Becton
• Dickinson and Company Merck KGaA
• Bio-Rad Laboratories